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Arginine-rich protein motifs have been described as potent cell-penetrating peptides 
(CPPs) but also as rather specific ligands of the cell surface chemokine receptor 
CXCR4, involved in the infection by the human immunodeficiency virus (HIV). 
Polyarginines are commonly used to functionalize nanoscale vehicles for gene therapy 
and drug delivery, aimed to enhance cell penetrability of the therapeutic cargo. 
However, under which conditions these peptides do act as either unspecific or specific 
ligands is unknown. We have here explored the cell penetrability of differently charged 
polyarginines in two alternative presentations, namely as unassembled fusion proteins 
or assembled in multimeric protein nanoparticles. By this, we have observed that 
arginine-rich peptides switch between receptor-mediated and receptor-independent 
mechanisms of cell penetration. The relative weight of these activities is determined 
by the electrostatic charge of the construct and the oligomerization status of the 
nanoscale material, both regulatable by conventional protein engineering approaches. 
 
 








The cell surface chemokine receptor CXCR4 is of high clinical relevance, as it acts as 
a co-receptor during the cell infection by the human immunodeficiency virus (HIV) [1]. 
In addition, CXCR4 is a pivotal cancer marker overexpressed in the stem cells of more 
than 20 human neoplasias, including frequent ones such as colorectal and pancreatic 
cancers and lymphoma [2]. In colorectal cancer, overexpression of CXCR4 is 
correlated with aggressiveness and metastatic potential. This fact has attracted 
interest over this membrane protein as a potential target for drug delivery [3-5]. 
Polyarginines (like R9 and others) are cell penetrating peptides (CPPs) that being 
cationic, efficiently condensate nucleic acids and promote nuclear localization of 
attached molecules [6]. Such pleiotropic profiling has empowered some members of 
the Rn series as valuable functionalizing agents in gene therapy and non-targeted drug 
delivery. However, under some experimental conditions, polyarginines such as R12 
(but not R8), presented as free synthetic peptides, are endocyted by cultured cells in 
a CXCR4-dependent fashion [7]. In addition, it has been recently reported that a 
fraction of R9-displaying bacterial amyloids internalize cultured cells by direct binding 
to CXCR4 [8], while a part of the material penetrates by rather unspecific mechanisms. 
The possibility to specifically mediate the internalization of macromolecular complexes 
via CXCR4 is highly appealing in the context of drug delivery. Then, appropriate 
polyarginine candidates might represent novel and valuable peptidic ligands for 
CXCR4 that might offer innovative pharmacological opportunities over the currently 
explored peptide ligands of CXCR4, whose performance is highly variable [9]. In this 
context, it would be very convenient to define the optimal form and presentation of a 
given polyarginine domain to unbalance the alternative routes of cell penetration to 
favour the specific, CXCR4-dependent cell penetrability. This is of special interest 
when polyarginines are linked to high molecular weight cargos such as full-length 
recombinant proteins or different types of nanoparticles or other nanostructured 
entities. Then, we have explored here the dependence on CXCR4 in the internalization 
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of four members of the Rn family when fused to a soluble functional GFP. The 
fluorescent protein acts as a convenient reporter for image-based monitoring and 
analysis and as an efficient building block for the generation of protein-based 
nanoparticles [10]. We have specially focused our study on the length of the cationic 
segment (the n value) and on the multivalent versus monovalent display of the ligand 
on the surface of the protein material. By taking this approach, we have identified both 







Proteins and protein production 
Four GFP-derived fusion proteins, namely R3-GFP-H6, R6-GFP-H6, R7-GFP-H6 and 
R9-GFP-H6 [11] were used in the present study upon recombinant production in 
bacteria. As previously described, R9-GFP-H6 was modified by directed mutagenesis 
to generate the other constructions, replacing arginines by glycines and alanines, in 
order to maintain the same length of peptide tag with different charges [11]. All of the 
fusion proteins are based on the same modular scheme (Figure 1A), in which the 
cationic peptide is placed at the N-terminal end of a His-tagged GFP. For highly 
cationic peptide segments such arrangement promotes the self-assembling of GFP as 
highly stable protein nanoparticles, which act as multivalent materials usable as 
vehicles for cell-targeted drug delivery [12-14]. Escherichia coli Rosetta (Novagen, 
Madison, WI, USA) was grown in shaker flask in Lysogenic broth (LB) medium 
containing 34 mg/ml chloramphenicol, 12.5 mg/ml tetracycline (strain resistance) and 
100 mg/ml ampicillin (vector resistance) at 37 ºC 250 rpm, to reach an OD550 of ~0.6 
units. Then, induction of gene expression was triggered by 0.1 mM isopropyl-b-D-
thiogalactopyronaside (IPTG, Merck, Kenilworth, NJ, USA), and it was prolonged 
overnight at 20 ºC. Bacterial cells were collected by centrifugation and resuspended in 
Wash buffer (20 mM Tris , 500 mM NaCl, 10 mM Imidazole; pH 8.0) in the presence 
of EDTA-Free protease inhibitor (Complete EDTA-Free; Roche, Manheim, Germany), 
to be disrupted at 1200 psi using a French Press (Thermo FA-078A, Thermo Electron 
Corporation, Needham Heights, MA, USA). The soluble fraction of lysed cells was 
loaded on a HiTrap Chelating HP 1 ml column (GE Healthcare, Chicago, IL, USA) to 
be purified by 6x His-tag affinity chromatography on an ÄKTA purifier (GE Healthcare, 
Chicago, IL, USA). Bound proteins were eluted with Elution Buffer (20 mM Tris , 500 
mM NaCl, 500 mM Imidazole; pH 8.0) in a linear gradient, and fractions containing the 
protein were then dialysed overnight at 4 ºC against Tris Dextrose buffer (20 mM Tris 
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5 % dextrose; pH 7.4, referred as Dextrose in the Figures) or Tris NaCl buffer (20 mM 
Tris, 500 mM NaCl; pH 7.4, referred as NaCl in the Figures), depending on the 
solubility of each protein. The purity of the protein was determined by denaturing SDS-
polyacrylamide gel electrophoresis (12 % polyacrylamide) and anti-6x-His-tag Western 
Blot. Concentrations were determined by Bradford’s assay. R9-GFP-H6 had been 
extensively characterized regarding several of its physicochemical properties, 
including self-assembling [15]. 
 
Fluorescence determination and dynamic light scattering (DLS) 
The specific fluorescence of protein variants was determined in a Varian Cary Eclipse 
Fluorescence Spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) with 
all proteins being diluted to the same concentration (0.1 mg/ml). For measurements, 
samples were excited at a wavelength of 488 nm and the emission collected in the 
range 500-548 nm, with maximum emission detected at 510 nm. Volume size 
distribution of nanoparticles and monomeric proteins were determined by dynamic light 
scattering at 633 nm (Zetasizer Nano ZS, Malvern Instruments Limited, Malvern, 
Worcestershire, UK). Measurements were performed in triplicate. For disassembling 
assays, SDS (to 0.1 % or 0.05 %, final) was added to proteins previously diluted at 1 




Morphometry (size and shape) of representative nanoparticles was evaluated 
quantitatively and qualitatively both with field emission scanning electron microscopy 
(FESEM) and transmission electron microscopy (TEM). Drops of 3 µl of R7-GFP-H6 
in both Tris Dextrose and Tris NaCl buffers and R9-GFP-H6 in Tris Dextrose buffer 
were directly deposited on silicon wafers (Ted Pella Inc., Redding, CA, USA) for 1 min, 
excess blotted with Whatman filter paper number 1 (GE Healthcare, Little Chalfont, 
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UK), air dried, and immediately observed without coating at a nearly native state in a 
FESEM Zeiss Merlin (Zeiss, Oberkochen, Germany) operating at 1 kV with a high 
resolution in-lens secondary electron detector. Drops of 3 µl of the same three samples 
were directly deposited on 200 mesh carbon-coated copper grids (Electron Microscopy 
Sciences, Hatfield, PA, USA) for 1 min, excess blotted with Whatman filter paper 
number 1 (GE Healthcare), contrasted with 3 µl of 1 % uranyl acetate (Polysciences 
Inc., Warrington, PA, USA) for 1 min, blotted again and observed in a TEM Jeol 1400 
(Jeol Ltd., Tokyo, Japan) operating at 80 kV with a Gatan Orius SC200 CCD camera 
(Gatan Inc. Abingdon, UK), For each sample and EM technique, the size of 50 
randomly distributed particles was measured from TIFF and DM3 files with ImageJ 
software (NIH, Bethesda, MA,USA). 
 
Cell culture and internalization 
HeLa (ATCC-CCL-2, ATCC, Manassas, VA, USA) cells were cultured in MEM-alpha 
(GIBCO) supplemented with 10 % Foetal Calf Serum (GIBCO BRL, Grand Island, NY, 
USA) and incubated at 37ºC and 5 % CO2. For internalization assays, cells were grown 
in 24-well plates on complete medium, which was replaced by OptiPro supplemented 
with L-Glutamine before the addition of the proteins. After 2 or 24 h of incubation, cells 
were detached from the plate with Trypsin (GIBCO) 1 mg/ml for 15 min before being 
analysed by flow cytometry on a FACS Canto (Becton Dickinson, Franklin Lakes, NJ, 
USA). Protein fluorescence was excited using a 15 mW air-cooled argon ion laser at 
488 nm and detected by a 530/30 nm band pass filter D detector. In all internalization 
experiments the same concentration of protein was used (1 or 2 µM, as specified). The 
results were corrected with the fluorescence values obtained from fluorimeter to render 
data comparable in terms of protein mass. For competition assays, the specific CXCR4 
antagonist AMD3100 [16] (octahydrochloride hydrate, Sigma-Aldrich) was added to 
fresh OptiPRO medium to a 1:10 (protein: AMD3100) molar ratio. Nanoparticles were 





For confocal microscopy HeLa cells were grown on Mat-Tek plates (MatTek 
Corporation, Ashland, MA, USA). The nuclei were labelled with 10 µg/ml Hoechst 
33342 (Invitrogen, Waltham, MA, USA) and the plasma membrane with 2.5 µg/ml 
CellMaskTM Deep Red (Molecular Probes, Eugene, OR, USA) for 10 min at room 
temperature and then washed in PBS buffer (Sigma-Aldrich Chemie GmbH, 
Taufkirchen, Germany). Live cells were recorded by TCS-SP5 confocal laser 
microscopy (Leica Microsystems, Wetzlar, Germany) using a Plan Apo 63x/1.4 (oil HC 
x PL APO lambda blue) objective. Hoechst 33342 DNA label was excited with a blue 
diode (405 nm) and detected in the 415–460 nm range. GFP-proteins were excited 
with an Ar laser (488 nm) and detected in the 525–545 nm range. CellMask™ Deep 
Red was excited with a HeNe laser (633 nm) and detected in the 650–775 nm range. 
To determine the protein localization inside the cell, stacks of 20–30 sections were 
collected with 0.5 μm of thickness, and 3D models were generated using  the Leica 
LAS X software (Leica Microsystems, Wetzlar, Germany).  
 
Statistical analysis 
Values are expressed as mean data and standard error (x̅ ± SD). Data were tested for 
normal distribution and for homogeneity of variance prior the use of parametric tests 
with Kolmogorov-Smirnov and Levene tests, respectively. Multiple comparisons were 
performed by one-way ANOVAs followed by Fisher's least significant difference (LSD, 
two tailed) and pairwise comparisons by two-tailed Student t-tests using Microsoft 





To model the penetration of protein nanoparticles in a kinetic way we selected the 
simplest model by assuming a constant rate of nanoparticle uptake m(t) as a function 
of time t, 
𝑑𝑚
𝑑𝑡
= −𝑘, 0 ≤  𝑘 <  1 
 
⇒  𝑚(𝑡) =  𝑀𝑒−𝑘𝑡  (1) 
 
The intracellular fluorescence emission f(t) is proportional to the amount of internalized 
protein,  
 
𝑓(𝑡) = 𝐿 (1 − 𝑒−𝑘𝑡)     (2) 
 







  = 𝐿𝑘 ≡ 𝑣     (3) 
 
The value of k refers to the time τ= 𝑙𝑛2/𝑘 needed to reach one half of the maximum 
fluorescence L accumulated in target cells. The model depends on the parameter k 
and the integration constant L. To determine k and L, two couples of measurements 
(2 h and 24 h) were employed, namely t1, f1 = f(t1), and t2, f2 = f(t2). We assume t1 < t2; 
f1 < f2. Therefore, according to Eq. (2), 
 
𝑘 =  −
1
𝑡1
ln ( 1 −
𝑓1 
𝐿
) =  −
1
𝑡2
 ln (1 −
𝑓2
𝐿
)   (4) 
 
By defining x = f1/L < 1, μ = t2/t1 > 1, and α = f2/f1 > 1, the second equality in the 
above equation leads to the following non-linear equation 
 




If μ is an integer, the above equation is a polynomial. In a general case, a fixed point 
Newton-Raphson method will be applied to obtain the single root x0 satisfying 0 < x0 
< 1. Finally, we get k = −
1
𝑡1










R3-GFP-H6, R6-GFP-H6, R7-GFP-H6 and R9-GFP-H6 (Figure 1, A) were 
successfully bio-produced in E. coli (Figure 1B) and stored in either Tris Dextrose 
buffer (named as Dextrose in the Figures) or Tris NaCl buffer (named as NaCl in the 
Figures), depending on their solubility. R3 and R6 derivatives were preferentially 
soluble in Tris NaCl buffer, R9 in Tris Dextrose buffer and R7 was found to be soluble 
in both (data not shown). All produced proteins were fluorescent, although with 
important variability between the checked species (Figure 1, C). This observation, 
strongly suggested a differential impact (direct or indirect) of the differently charged 
amino terminal Rn tails on the folding status of the GFP variants. Since the buffer is 
not expected to affect fluorescence by itself, oligomerization and associated 
conformational changes might affect the emission capacity of the fluorophore or 
quench it. When analysing by DLS the potential of these constructs to form 
nanoparticles, linked to the nature of the cationic terminal domain, we confirmed the 
inability of R3 and R6 to promote self-assembling (Figure 2), in agreement with a 
previous preliminary screening [11]. Interestingly, R7-GFP-H6 showed self-
assembling properties in Tris Dextrose resulting in nanoparticles of about 30 nm, but 
not in Tris NaCl in which the protein remained unassembled (Figure 2,  and Figure 3, 
A and B). The higher salt content in the latest buffer might interfere with the 
electrostatic interactions needed between building blocks to start the oligomerization 
process [11], thus preventing nanoparticle formation. As previously described [15], R9-
GFP-H6 efficiently assembled as regular, toroid-shaped materials of about 30 nm  
(Figure 2). The size measurements of nanoparticles obtained from FESEM and TEM 
images were in deep agreement with the values obtained by DLS (Figures 2, 3). In 
Dextrose-containing buffer, the R9-GFP-H6 nanomaterial appeared larger than in 
conventional buffers [15], as the sugar probably stabilizes protein-protein cross-
interactions. Interestingly, the protein versions that self-organize as oligomers 
rendered lower fluorescence emission levels than those that remained as building 
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blocks (Figure 1, C). This fact indicated that the architectonic organization of the whole 
material has an impact on the fluorescent emission of the core GFP, either by a 
perturbation on the individual building block conformation, as suggested by previous 
analyses of related self-assembling fluorescent proteins [10, 17], or by fluorophore 
quenching due to specific protein-protein cross interactions [18]. Irrespective of these 
differences, the fluorescence emission was, in all cases, high enough to monitor fast 
and accurately the cell internalization process upon exposure, and for the evaluation 
of the potential mediation of CXCR4 in the uptake process. 
 
Cell penetrability of all these constructs was explored by the accumulation of 
intracellular fluorescence in cultured HeLa cells exposed to them, after a harsh trypsin 
treatment to remove externally associated protein. As observed (Figure 4A), all 
proteins penetrate cells since early contact times in a dose-dependent manner, with 
efficacies that clearly depend on the number of arginines composing the tag at the 
protein amino terminus. Previous studies showed that 6-12 arginine residues are 
necessary to promote unspecific entry, with guanidino groups forming hydrogen bonds 
and ion-pairs with lipid head groups and hydrophobic tails to assist in membrane 
binding [19]. Here we observed that differences between  proteins  were  largely  
amplified  at  long  exposure  times  (24  h), especially  in  the  case  of  R9-GFP-H6,  
that  was  clearly  superior  than  the  related polypeptides in the uptake.  
 
Although the number of arginine residues had been implicated in membrane 
permeability [20], there was a lack of systematic comparisons to clearly understand 
the role of oligomerization in promoting internalization and how the entry mechanism 
is affected by these factors. At 24 h, a penetrability of the assembled R7-GFP-H6 (in 
Tris Dextrose) higher than the unassembled version (in Tris NaCl) was evidenced, 
pointing out the assembled form and the multivalent display of R7 as favouring agents 
of cell uptake. Although the number of arginine residues was a parameter that 
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positively affected internalization, multimerization appeared to have an additive and 
more potent weight. Confocal imaging of the penetration process (Figure 4 B and C) 
revealed clustering of fluorescent materials in the perinuclear region essentially in the 
case of the R9-based construct, with an intracellular distribution that might be 
compatible with both endosomal uptake and transmembrane penetration. In this 
regard, it must be stressed that endocytic vesicles engulfing fluorescent material were 
hardly identified during the penetration of R9-GFP-H6, while they were more apparent 
in the penetration of the assembled R7-GFP-H6. In this regard, it must be noted the 
merging yellow signal (co-localization between red membrane and green protein, 
arrows) revealed in confocal images of cells exposed to R7-GFP-H6 nanoparticles 
(Figure 4 B). 
 
It has been reported that CXCR4 is involved in internalization of R12 through 
macropinocytosis, while R8 and TAT seemed to follow a CXCR4-independent route 
[7]. To determine the involvement of CXCR4 as mediator of internalization of R7 and 
R9, we monitored this event in presence of AMD3100, a chemical ligand of CXCR4 
that inhibits the binding of CXCR4-reactive proteins [16, 21]. As observed (Figure 5, 
A), at early times after exposure the CXCR4 specificity of the uptake of monomeric 
versions increases with the number or arginine residues in a linear way. However, the 
multivalent presentation of polyarginines seemed to promote receptor-independent 
penetrability, probably linked to the CPP nature of Rn, since the intracellular 
accumulation of fluorescence is poorly prevented by AMD3100 in the case of the 
oligomers. However, after 24 h of exposure, the inhibitory effect of AMD3100 was 
clearly more evident in the case of R9-GFP-H6 (and also R7-GFP-H6) than in the rest 
of the materials. In this context, it must be noted that the assembled R7 and R9 
versions of GFP are indistinguishable regarding stability, as both are equally 
dissociated by different concentrations of SDS (Figure 5, B). Therefore, dissociation 
for R7 and R9 constructs (and differential dissociation) was not expected under these 
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experimental conditions. Since both the number of N-terminal arginine residues and 
the oligomerization process might influence efficiency and specificity of protein 
penetration is highly relevant for the design of cell-targeted nanoparticle, we presented 
the obtained data (from Figure 5, A) in a more visual way for further analysis.  
 
As observed (Figure 6, A), the number of arginine residues positively influenced the 
amount of internalized fluorescence both 2 h and 24 h upon exposure. Oligomerization, 
affecting only R7- and R9-based materials, showed a moderate impact on the global 
uptake process that was dissimilar when comparing short and long times. On the other 
hand, the % of uptake inhibition mediated by AMD3100 also increased along the 
number of arginine residues, at 24 h but not from the determinations done 2 h upon 
exposure. While the specificity for CXCR4 appears as being globally gained by the 
accumulation of cationic residues, that progressively convert Rn-based CPPs into 
CXCR4 ligands, data also suggested a differential uptake mechanisms acting at short 
and long incubation times. To better analyze this possibility, we modelled the 
penetration of protein nanoparticles in a kinetic way. For that, we explored the factors 
L, k, τ and v as defined in the materials and methods section. When these parameters 
were determined versus the number of arginine residues at the N terminus of the 
proteins (Rn) for exposures in absence and in presence of the inhibitor AMD3100, we 
obtained graphical determinations of their behaviour (Figure 6, B). Importantly, the 
global amount of internalized protein L increased with the Rn value, confirming the 
positive impact that the number of arginines has in the global penetrability of proteins, 
that appears as being further (but slightly) enhanced by the oligomerization of the 
building blocks.  
 
Irrespective of the precise mechanism of entrance, this can be accounted by the 
increase in the positive charge, but also by the multivalent exposure of Rn versus a 
monovalent display in unassembled proteins [3]. On the other hand, the initial 
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penetration velocity of proteins (v) increased with Rn values for unassembled proteins 
but it was inversely proportional to the number of arginines in the nanoparticles. In 
presence of AMD3100, that blocks CXCR4-specific penetration and only unspecific 
CPP-based uptake is allowed, v tends to be constant. This is indicative that the number 
or arginines impacts only (or majorly) on the receptor-dependent penetration of the 
proteins, which starts very fast upon protein-cell contact. In addition, the comparative 
behaviour of v in absence and in presence of AMD3100 also indicates that 
oligomerization globally enhances the CPP properties of proteins, a fact that promotes 
a fast and early entrance into the cells upon exposure. Inversely, oligomerization, and 
the increase of the number of arginine residues in the oligomers minimized specificity 
in early penetration stages. By analyzing k, which can be also interpreted in terms of 
the half time (τ) to reach the maximal intracellular accumulation of protein, we 
determined that the jump from R7 to R9 (but not oligomerization itself) expands the 
time period in which the penetration process does occur. However, when AMD3100 is 
present, the duration of the penetration process is also expanded depending on the 
Rn value. Therefore, the unspecific penetrability of Rn-based nanoconstructs 
sustained by their CPP properties is a time-prolonged process that is favoured when 






The delivery of therapeutic molecules into cells requires the smart engineering of 
fusogenic agents, mainly lipids [22, 23] and proteins [24, 25], that act as unspecific but 
highly efficient cell penetrating agents. Alternatively, cell-targeting tools, such as 
antibodies or peptidic ligands, provide selectivity in the cell binding of drug vehicles 
[26, 27], although they are generically less competent than unspecific CPP tools in 
promoting internalization [28, 29]. The still poorly explored combination of both agents 
in the same vehicle, namely the incorporation of a CPP and a peptidic ligand of a target 
cell surface receptor has so far resulted in very high cell penetration levels but at 
expenses of specificity [30].  
 
Among the CPPs recognized as useful and with potential for realistic development and 
applicability in biomedicine, arginine-rich peptides are indeed being translated from 
bench to bedside in several pre-clinical and clinical trials [31]. Even though the 
internalization mechanisms of polyarginines are not completely understood, they are 
being combined to different formulations due to their penetration enhancing properties, 
being applied even in highly challenging conditions such as oral administration [32]. 
Interestingly, it has been separately suggested that polyarginines exhibit either 
unspecific (CPP) or specific (receptor-dependent) cell penetration activities [7, 8]. 
Receptor-dependent internalization of polyarginines can be seen as an entangled 
scenario affected by multiple factors. For instance, the contribution of Syndecan-4, a 
receptor known to be involved in R8 internalization, was also reported to depend on 
parameters such as the extracellular concentration of the peptide but not affected by 
the presence of a protein fused to R8 [33].  
 
This unusual pleiotropic profile might be highly relevant when designing new 
generation protein-based vehicles for cell-targeted drug delivery, especially regarding 
efficiency and when looking for selectivity in a drug delivery process. Therefore, the 
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highly versatile mechanism of entry of polyarginines has been dissected here through 
the use of several Rn constructs, showing or not self-assembling properties that affect 
the multivalent display of the peptide to exposed cells. In this context, the obtained 
data indicate the coexistence of two different mechanism of penetrability of Rn-
empowered proteins, namely CXCR4-dependent uptake and unspecific CPP-based 
internalization, which act differentially during the time of contact between cells and 
materials. In presence of free CXCR4 on the cell surface, proteins probably remain 
attached to the receptor and initiate a fast process of penetration. When CXCR4 is 
blocked by AMD3100, or CXCR4 paratopes are saturated by earlier contacts, cell 
penetrability is unspecific and takes place much slower (Figure 5). The relative 
prevalence of both mechanisms is also largely influenced by the value of Rn and by 
the oligomerization status of the protein. The specificity in the cell penetration is 
reduced by oligomerization and by the Rn value of the oligomers at short times upon 
exposure (Figure 6). However, globally, the increase of Rn length and the formation of 
multivalent structures increase the total amount of intracellular material and its 
receptor-depended uptake.  
 
In summary, despite polyarginines have been generically observed as highly potent 
CPPs useful as an internalization tag in cell therapy and drug delivery [6], their known 
residual specificity for the cell surface cytokine receptor CXCR4 can be enhanced by 
a proper presentation of the cationic stretch. As shown here, this can be achieved by 
extending the number of arginine residues and, with a milder impact, of the multimeric 
presentation on the surface of targeting vehicles. Since polyarginines are highly 
cationic and they act also as oligomerization domains [9], R9 and related species can 
confer to fusion proteins both self-assembling and cell-targeting properties. Being 
CXCR4 an appealing target in innovative cancer therapies and in antiretroviral 
treatments [2, 4, 5, 7, 16, 21, 34-37], R9 and related peptides might represent an 
additional instrument for the design of improved vehicles for intracellular drug delivery. 
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Albeit the CXCR4 specificity of polyarginines might not be absolute, even in their 
optimal presentation (Figure 5, A), their use in combination with other CXCR4 ligands 
might allow the generation of new-generation bi-paratopic vehicles, that are extremely 
appealing for enhanced specificities and cell surface avidity in receptor-mediated drug 
delivery [38-42]. In vehicles with such combined functional agents, the residual CPP 
activities of polyarginines might enhance penetrability and endosomal escape more 
efficiently than completely unspecific fusogenic peptides that such as HA2, tend to 
impair selectivity of the accompanying cell ligands [30].  
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Figure 1. Production and preliminary characterization of Rn-containing GFP protein 
versions. A. Generic scheme of the modular protein construction. The linker sequence is 
GGGNS, and the precise amino acid sequence of the Rn peptides is indicated in the box. B 
Coomassie blue-stained PAGE-SDS gel showing the integrity and purity of Rn-GFP-H6 
recombinant proteins upon affinity chromatography (left). Proteolytic stability was confirmed by 
Western blot (right). The type of buffer used is indicated at the top, as well as the number of 
amino-terminal arginine residues in each protein. The molecular mass of relevant markers (M) 
is indicated in kDa. C. Fluorescence emission spectra of equal amounts of each protein. 
 
Figure 2. Assembling of Rn-containing GFP proteins. DLS size determination of protein 
self-assembling. The size of unassembled proteins (6-8 nm) might correspond to GFP dimers 
acting as building blocks. In the inset, peak (expressed in nm) and PDI as mean values and 
standard deviation (x̅ ± SD) for each protein sample obtained by DLS. 
 
Figure 3. Ultrastructural analysis of Rn-containing GFP proteins.  FESEM and TEM 
imaging of protein nanoparticles formed in Dextrose buffer. Representative fields of R7-GFP-
H6 samples in NaCl buffer are also shown as negative controls. Bars size is 20 nm. The  size 
of the nanomaterials (in nm) determined from images is indicated  as mean values and standard 
deviation (x̅ ± SD)  for each protein sample and EM technique (nd indicates that the material 
has not been detected). 
 
Figure 4. Cell penetrability of Rn-containing GFP proteins. A. Intracellular fluorescence 
accumulated in CXCR4+ HeLa cells upon exposure to unassembled and assembled Rn-based 
proteins, for different times and protein doses. Symbols are ** p< 0.01; * p < 0.05. B. 
Conventional confocal images of target HeLa cells exposed for 24 h to 2 µM of either R7 or R9-
based proteins. The green signal results from the protein fluorescence, while red signals label 
membranes and blue signals the cell nuclei. Arrows indicate yellow merging signals. C. 3D 
reconstructions based on stacks of 20–30 sections of protein-exposed HeLa cells. In the insets, 




Figure 5. CXCR4-dependence in the internalization of Rn-based protein materials. A. 
Accumulation of intracellular fluorescence into CXCR4+ HeLa cells associated to different Rn-
based materials, and AMD3100-mediated inhibition of the process. The signals were recorded 
at two different times after exposure. Symbols are ** p< 0.01; * p < 0.05. B. DLS size 
measurements of R7 and R9-based proteins upon incubation with SDS for 10 min.  
 
Figure 6. Internalization of Rn-based protein materials. A. Intracellular florescence in HeLa 
cells and percentage of AMD3100-mediated uptake inhibition upon 2 h and 24 h of exposure 
to Rn-based nanoparticles. B. Plotting of main kinetic parameters of protein uptake, namely L, 
τ, , k and v (see Eq 1-3) versus the number of arginine residues at the N-terminus of proteins 
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